← Evidence map

ReviewCurrent pharmaceutical design2012

Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target.

Vladimír Krystof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

58 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22571657